Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current trends in managing oral mucositis.

Margaret M Cawley1, Laura M Benson

  • 1mmc9006@nyp.org

Clinical Journal of Oncology Nursing
|October 21, 2005
PubMed
Summary

Oral mucositis, an inflammatory condition affecting the mouth, frequently occurs during cancer treatments like chemotherapy and radiotherapy. Early intervention and supportive care are crucial for managing this side effect and improving patient quality of life.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gender in clinical neuropsychology: practice survey trends and comparisons outside the specialty.

The Clinical neuropsychologist·2017
Same author

The American Academy of Clinical Neuropsychology, National Academy of Neuropsychology, and Society for Clinical Neuropsychology (APA Division 40) 2015 TCN Professional Practice and 'Salary Survey': Professional Practices, Beliefs, and Incomes of U.S. Neuropsychologists.

The Clinical neuropsychologist·2016
Same author

An initial report of sleep disturbance in inactive inflammatory bowel disease.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2007
See all related articles

Area of Science:

  • Oncology
  • Oral Medicine
  • Pathophysiology

Background:

  • Oral mucositis is a common and debilitating side effect of cancer therapies, including chemotherapy and radiotherapy.
  • It affects the oral mucosa, leading to inflammation and ulceration, significantly impacting patients' quality of life.

Observation:

  • The incidence of oral mucositis varies, ranging from 15%-40% in patients receiving chemotherapy or radiotherapy to 70%-90% in bone marrow recipients.
  • Understanding the evolving pathophysiology of oral mucositis is essential for guiding clinical practice.
  • Various assessment tools exist to measure mucositis severity, but no single tool is universally applicable.

Findings:

  • Oral mucositis significantly impacts a patient's quality of life and can disrupt treatment plans.
  • Effective management strategies focus on minimizing this side effect through early intervention and supportive care.
  • Targeted therapies are available for managing the debilitating symptoms of oral mucositis.

Implications:

  • This overview highlights the importance of recognizing risk factors, understanding pathophysiology, and utilizing appropriate assessment tools for oral mucositis.
  • Implementing comprehensive management strategies, including supportive care and targeted therapies, is crucial for mitigating the impact of oral mucositis.
  • Nursing implications involve early identification, intervention, and ongoing support for patients at risk or experiencing oral mucositis.

Related Experiment Videos